Found: 76
Select item for more details and to access through your institution.
Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes.
- Published in:
- Cellular Microbiology, 2004, v. 6, n. 8, p. 695, doi. 10.1111/j.1462-5822.2004.00423.x
- By:
- Publication type:
- Article
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
- Published in:
- Journal of NeuroVirology, 2007, v. 13, n. 6, p. 549, doi. 10.1080/13550280701591526
- By:
- Publication type:
- Article
The under‐appreciated world of the serpin family of serine proteinase inhibitors.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 6, p. 1, doi. 10.15252/emmm.202217144
- By:
- Publication type:
- Article
Deriving Immune Modulating Drugs from Viruses—A New Class of Biologics.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 972, doi. 10.3390/jcm9040972
- By:
- Publication type:
- Article
Oncolytic Virotherapy with Myxoma Virus.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 171, doi. 10.3390/jcm9010171
- By:
- Publication type:
- Article
A Virus-Derived Immune Modulating Serpin Accelerates Wound Closure with Improved Collagen Remodeling.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1626, doi. 10.3390/jcm8101626
- By:
- Publication type:
- Article
Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 244, doi. 10.3390/vaccines8020244
- By:
- Publication type:
- Article
A cautionary note on the selectivity of oncolytic poxviruses.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 3, doi. 10.2147/OV.S189832
- By:
- Publication type:
- Article
Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.
- Published in:
- Oncolytic Virotherapy, 2013, v. 2, p. 1, doi. 10.2147/OV.S37971
- By:
- Publication type:
- Article
Oncolytic virotherapy for ovarian cancer.
- Published in:
- Oncolytic Virotherapy, 2012, v. 1, p. 1, doi. 10.2147/OV.S31626
- By:
- Publication type:
- Article
Myxoma Virus Is Oncolytic for Human Pancreatic Adenocarcinoma Cells.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 8, p. 2329, doi. 10.1245/s10434-008-9924-z
- By:
- Publication type:
- Article
Gleevec casts a pox on poxviruses.
- Published in:
- Nature Medicine, 2005, v. 11, n. 7, p. 711, doi. 10.1038/nm0705-711
- By:
- Publication type:
- Article
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-82
- By:
- Publication type:
- Article
The α2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118806
- By:
- Publication type:
- Article
Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109801
- By:
- Publication type:
- Article
Positive Evolutionary Selection On the RIG-I-Like Receptor Genes in Mammals.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081864
- By:
- Publication type:
- Article
Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas <i>In Vitro</i> and <i>In Vivo</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066825
- By:
- Publication type:
- Article
Resistance to Oncolytic Myxoma Virus Therapy in Nf1<sup>−/−</sup>/Trp53<sup>−/−</sup> Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065801
- By:
- Publication type:
- Article
Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043298
- By:
- Publication type:
- Article
Innate Immune Response of Human Plasmacytoid Dendritic Cells to Poxvirus Infection Is Subverted by Vaccinia E3 via Its Z-DNA/RNA Binding Domain.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036823
- By:
- Publication type:
- Article
Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010510
- By:
- Publication type:
- Article
Strategies that modulate inflammasomes—insights from host–pathogen interactions.
- Published in:
- Seminars in Immunopathology, 2007, v. 29, n. 3, p. 261, doi. 10.1007/s00281-007-0080-5
- By:
- Publication type:
- Article
Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1461, doi. 10.1007/s00262-011-1045-z
- By:
- Publication type:
- Article
Viral SERPINS—A Family of Highly Potent Immune-Modulating Therapeutic Proteins.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1393, doi. 10.3390/biom13091393
- By:
- Publication type:
- Article
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 2022, doi. 10.3390/cancers14082022
- By:
- Publication type:
- Article
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 337, doi. 10.3390/cancers14020337
- By:
- Publication type:
- Article
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5452, doi. 10.3390/cancers13215452
- By:
- Publication type:
- Article
Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1394, doi. 10.3390/cancers13061394
- By:
- Publication type:
- Article
Cytokine determinants of viral tropism.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Smallpox: anything to declare?
- Published in:
- 2002
- By:
- Publication type:
- journal article
Science and society: Smallpox: anything to declare?
- Published in:
- Nature Reviews Immunology, 2002, v. 2, n. 7, p. 521, doi. 10.1038/nri845
- By:
- Publication type:
- Article
Immunomodulation by viruses the myxoma virus story.
- Published in:
- Immunological Reviews, 1999, v. 168, n. 1, p. 103, doi. 10.1111/j.1600-065X.1999.tb01286.x
- By:
- Publication type:
- Article
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 8, p. 1088, doi. 10.1093/neuonc/now006
- By:
- Publication type:
- Article
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1086, doi. 10.1093/neuonc/nou359
- By:
- Publication type:
- Article
Treating brain tumor–initiating cells using a combination of myxoma virus and rapamycin.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 904, doi. 10.1093/neuonc/not035
- By:
- Publication type:
- Article
PLoS Pathogens at Three Years.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
RIG-I Mediates the Co-Induction of Tumor Necrosis Factor and Type I Interferon Elicited by Myxoma Virus in Primary Human Macrophages.
- Published in:
- PLoS Pathogens, 2008, v. 4, n. 7, p. 1, doi. 10.1371/journal.ppat.1000099
- By:
- Publication type:
- Article
Change in the Editorial Leadership of PLoS Pathogens.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Antibody-Independent Control of γ-Herpesvirus Latency via B Cell Induction of Anti-Viral T Cell Responses.
- Published in:
- PLoS Pathogens, 2006, v. 2, n. 6, p. e58, doi. 10.1371/journal.ppat.0020058
- By:
- Publication type:
- Article
Modulation of Tumor Necrosis Factor by Microbial Pathogens.
- Published in:
- PLoS Pathogens, 2006, v. 2, n. 2, p. 0066, doi. 10.1371/journal.ppat.0020004
- By:
- Publication type:
- Article
A Surface Groove Essential for Viral Bcl-2 Function During Chronic Infection In Vivo.
- Published in:
- PLoS Pathogens, 2005, v. 1, n. 1, p. 80, doi. 10.1371/journal.ppat.0010010
- By:
- Publication type:
- Article
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Harvesting viral proteins.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1999, v. 161, n. 9, p. 1134
- By:
- Publication type:
- Article
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier.
- Published in:
- Nature Immunology, 2004, v. 5, n. 12, p. 1266, doi. 10.1038/ni1132
- By:
- Publication type:
- Article
Convergent Loss of the Necroptosis Pathway in Disparate Mammalian Lineages Shapes Viruses Countermeasures.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.747737
- By:
- Publication type:
- Article
Coinfections of Novel Polyomavirus, Anelloviruses and a Recombinant Strain of Myxoma Virus-MYXV-Tol Identified in Iberian Hares.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 3, p. 340, doi. 10.3390/v12030340
- By:
- Publication type:
- Article
Genetic Characterization of a Recombinant Myxoma Virus in the Iberian Hare (Lepus granatensis).
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 6, p. 530, doi. 10.3390/v11060530
- By:
- Publication type:
- Article
Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion.
- Published in:
- Viruses (1999-4915), 2017, v. 9, n. 2, p. 27, doi. 10.3390/v9020027
- By:
- Publication type:
- Article
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies.
- Published in:
- Viruses (1999-4915), 2016, v. 8, n. 3, p. 85, doi. 10.3390/v8030085
- By:
- Publication type:
- Article
Introducing “Research Matters”.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 6, p. 1, doi. 10.1371/journal.ppat.1005014
- By:
- Publication type:
- Article